text
stringlengths 0
146
|
|---|
Chronic Adrenal Insufficiency
|
(Addison's Disease)
|
The coverage of this Special CI conditions benefit will be
|
provided until the day before the policy anniversary
|
immediately after the life insured's 85th birthday or the benefit
|
end date of this policy, whichever is earlier.
|
An autoimmune disorder causing a gradual destruction of the
|
adrenal gland resulting in the need for life long glucocorticoid
|
and mineral corticoid replacement therapy. The disorder must
|
be confirmed by a specialist in endocrinology through one of the
|
following:
|
• ACTH simulation tests;
|
• insulin-induced hypoglycemia test;
|
• plasma ACTH level measurement;
|
• Plasma Renin Activity (PRA) level measurement.
|
Only autoimmune cause of primary adrenal insufficiency is
|
included. All other causes of adrenal insufficiency are excluded.
|
3
|
Chronic Relapsing
|
Pancreatitis
|
The coverage of this Special CI conditions benefit will be
|
provided until the day before the policy anniversary
|
immediately after the life insured's 85th birthday or the benefit
|
end date of this policy, whichever is earlier.
|
More than 3 attacks of pancreatitis resulting in pancreatic
|
dysfunction causing malabsorption needing enzyme
|
replacement therapy.
|
The diagnosis must be made by a consultant gastroenterologist
|
and confirmed by Endoscopic Retrograde
|
Cholangiopancreatography (ERCP).
|
Chronic Relapsing Pancreatitis caused by alcohol use is
|
excluded.
|
4
|
Dengue Heamorrhagic Fever
|
The coverage of this Special CI conditions benefit will be
|
provided until the day before the policy anniversary
|
immediately after the life insured's 85th birthday or the benefit
|
end date of this policy, whichever is earlier.
|
Dengue Haemorrhagic Fever Stage 3 or Stage 4, based on the
|
World Health Organization case definition (1997), with
|
unequivocal evidence of the Dengue Shock Syndrome and
|
confirmation of dengue infection, with confirmatory serological
|
testing of dengue; and as exemplified by the following findings:
|
history of continuous high fever (for two (2) or more days),
|
• minor or major haemorrhagic manifestations,
|
• thrombocytopenia (less than or equal to 100000 per mm3)
|
• haemoconcentration (haemotocrit increased by 20% or more)
|
and
|
• evidence of plasma leakage (i.e. pleural effusion, ascites or
|
hypoproteinaemia, etc.)
|
Manulife CI FlexiCare (Deluxe) v0123
|
Page 37 of 42
|
Manulife (Singapore) Pte. Ltd.
|
A Manulife Company
|
No
|
Covered Special CI
|
Conditions
|
Definition
|
• evidence of the Dengue Shock Syndrome (DSS), confirmed by
|
a Specialist, with the following criteria being met:
|
- hypotension (less than 80 mm Hg) or narrow pulse pressure
|
(20 mm Hg or less) and
|
- evidence of tissue hypoperfusion such as cold, clammy skin,
|
oliguria, or a metabolic acidosis.
|
5
|
Diabetic Complications
|
The coverage of this Special CI conditions benefit will be
|
provided until the day before the policy anniversary
|
immediately after the life insured's 85th birthday or the benefit
|
end date of this policy, whichever is earlier.
|
Diabetic Retinopathy with actual undergoing of laser treatment
|
certified to be Medically Necessary by a Specialist with support
|
of Fluorescent Fundus Angiography report and vision measured
|
at 6/18 or worse in the better eye using a Snellen eye chart
|
before the procedure.
|
A definite diagnosis of diabetic nephropathy by a Specialist and
|
is evident by permanent eGFR less than 30 ml/min/1.73 m2
|
with ongoing proteinuria greater than 300mg/24 hours.
|
The actual undergoing of amputation of a leg / foot / toe / arm /
|
hand / finger to treat gangrene that has occurred because of a
|
complication of diabetes.
|
6
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.